Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Psychotic”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Post-approval studies (Phase 4)Study completedNCT00044187
What this trial is testing

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Who this might be right for
SchizophreniaPsychotic DisordersBipolar Disorder
Eli Lilly and Company 130
Testing effectiveness (Phase 2)Study completedNCT03510741
What this trial is testing

Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizoaffective Disorder
Pakistan Institute of Living and Learning 64
Early research (Phase 1)Study completedNCT00929955
What this trial is testing

Role of Anti-Inflammatory Agents in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychosis Not Otherwise Specified+1 more
Pakistan Institute of Living and Learning 36
Early research (Phase 1)Study completedNCT02943213
What this trial is testing

Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride

Who this might be right for
Anti-PsychoticManagement of Manifestations of Psychotic DisordersTreatment of Schizophrenia+6 more
Cycle Pharmaceuticals Ltd. 20
Not applicableUnknownNCT06238089
What this trial is testing

Anti-psychotic Drug Prescribing Patterns Within Specialist Adult ID Services in England and Wales

Who this might be right for
Intellectual Disability
University of Plymouth 600
Testing effectiveness (Phase 2)Study completedNCT00206544
What this trial is testing

Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?

Who this might be right for
Bipolar DisorderManiaSchizoaffective Disorder
The Alfred 51
Large-scale testing (Phase 3)Study completedNCT00300404
What this trial is testing

Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression

Who this might be right for
SchizophreniaMajor Depression
Zentrum für Integrative Psychiatrie 40
Testing effectiveness (Phase 2)WithdrawnNCT01272765
What this trial is testing

Anti-psychotic Medication (Stable Dose) Weight Loss Study

Who this might be right for
Obesity
Avera McKennan Hospital & University Health Center
Not applicableStudy completedNCT01347619
What this trial is testing

IADAPT: Off Label Use of Antipsychotics in the Nursing Home

Who this might be right for
Off-label Use of Atypical Antipsychotic Drugs
University of Massachusetts, Worcester 42
Not applicableStudy completedNCT02449746
What this trial is testing

Study of Immunotherapy in Autoantibody Positive Psychosis

Who this might be right for
SchizophreniaPsychosisAuto Immune Disorders
University of Cambridge 10
Testing effectiveness (Phase 2)Ended earlyNCT00686699
What this trial is testing

Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

Who this might be right for
Akathisia, Drug-InducedDyskinesia, Drug-InducedParkinsonian Disorders
Merck Sharp & Dohme LLC 11
Testing effectiveness (Phase 2)Study completedNCT00029458
What this trial is testing

Clozapine for Treatment-Resistant Mania

Who this might be right for
Bipolar Disorder
National Institute of Mental Health (NIMH) 42
Not applicableWithdrawnNCT02661347
What this trial is testing

Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia

Who this might be right for
SchizophreniaSchizophreniformSchizoaffective Disorder+1 more
Northwell Health
Post-approval studies (Phase 4)Looking for participantsNCT05823532
What this trial is testing

Anti-Inflammatory Challenge in Schizophrenia

Who this might be right for
Schizophrenia
Emory University 60
Large-scale testing (Phase 3)Study completedNCT00000179
What this trial is testing

Agitation in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
National Institute on Aging (NIA)
Post-approval studies (Phase 4)Ended earlyNCT00418873
What this trial is testing

Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward

Who this might be right for
Schizophrenia
Astellas Pharma Inc 39
Post-approval studies (Phase 4)UnknownNCT04020588
What this trial is testing

Anti-inflammatories and Adolescent Schizophrenia

Who this might be right for
Schizophrenia
Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico 90
Not applicableStudy completedNCT01514682
What this trial is testing

Anti-Inflammatory Treatment of Schizophrenia

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 50
Large-scale testing (Phase 3)Ended earlyNCT01908192
What this trial is testing

Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®

Who this might be right for
Schizophrenia
SyneuRx International (Taiwan) Corp 60
Testing effectiveness (Phase 2)Study completedNCT00968851
What this trial is testing

Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia

Who this might be right for
SchizophreniaCentral Nervous System DiseasesCognition
FORUM Pharmaceuticals Inc 317
Next Page